Login
$VRDN
$30.76 -$0.11 (0.36%) Live

$VRDN 8-K/A SEC Filings

Filed On Filing
15 Jun 2021 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

VIRIDIAN THERAPEUTICS, INC., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify:

01 Oct 2020 8-K/A: Departure/Election of Directors or Officers; Compensation

You are receiving this letter because you are a participant in the annual bonus program (the “Bonus Program”) of Miragen Therapeutics, Inc. (the “Company”). The Company is pleased to inform you that in gratitude for your efforts on behal...

27 Mar 2018 8-K/A: Departure/Election of Directors or Officers; Compensation

On March 21, 2018, Arlene M. Morris was named as a member of the nominating and corporate governance committee of the Company’s board of directors.

31 Mar 2017 8-K/A: Financial Statements and Exhibits

We have audited the accompanying consolidated balance sheets of Miragen Therapeutics, Inc. and subsidiary as of December 31, 2016 and 2015, and the related consolidated statements of operations, preferred stock and stockholders’ deficit,...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support